JCR Pharmaceuticals Co., Ltd.

62
Hold
  • Market Cap: Small Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: JP3701000006
JPY
445.00
-9 (-1.98%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationProfit and Loss Results
Results Snapshot
Figures in Million
Consolidated - Profit And Loss Results
Mar'26
Mar'25
Mar'24
Mar'23
Mar'22
Mar'21
No of Months
12
12
12
12
12
12
Operating Income
40,319.00
33,072.00
42,871.00
34,343.00
51,082.00
30,085.00
Less :Inter divisional transfers
0.00
0.00
0.00
0.00
0.00
0.00
Less: Excise
0.00
0.00
0.00
0.00
0.00
0.00
Net Sales
40,319.00
33,072.00
42,871.00
34,343.00
51,082.00
30,085.00
Expenditure (Ex Depriciation)
Stock Adjustments
0.00
0.00
0.00
0.00
0.00
0.00
Raw Materials Consumed
0.00
0.00
0.00
0.00
0.00
0.00
Power & Fuel Cost
0.00
0.00
0.00
0.00
0.00
0.00
Employee Cost
0.00
0.00
0.00
0.00
0.00
0.00
Operating Expenses
398.00
155.00
86.00
44.00
45.00
42.00
General and Administration Expenses
12,868.00
12,958.00
12,485.00
11,678.00
13,511.00
8,643.00
Selling and Distribution Expenses
0.00
0.00
0.00
0.00
0.00
0.00
Cost of Software developments
0.00
0.00
0.00
0.00
0.00
0.00
Miscellaneous Expenses
0.00
0.00
0.00
0.00
0.00
0.00
Expenses Capitalised
0.00
0.00
0.00
0.00
0.00
0.00
Total Expenditure
39,888.00
39,482.00
35,339.00
29,366.00
31,147.00
21,815.00
Operating Profit (PBDIT) excl Other Income
431.00
-6,410.00
7,532.00
4,977.00
19,935.00
8,270.00
Other Income
1,310.00
-482.00
-201.00
480.00
622.00
278.00
Operating Profit (PBDIT)
4,298.00
-3,518.00
10,528.00
7,454.00
22,502.00
10,440.00
Interest
398.00
155.00
86.00
44.00
45.00
42.00
Profit before Depriciation and Tax
0.00
0.00
0.00
0.00
0.00
0.00
Depreciation
2,557.00
3,374.00
3,197.00
1,997.00
1,945.00
1,892.00
Profit Before Taxation & Exceptional Items
0.00
0.00
0.00
0.00
0.00
0.00
Exceptional Income / Expenses
0.00
0.00
0.00
0.00
0.00
0.00
Profit Before Tax
3,224.00
-5,983.00
7,244.00
5,412.00
19,404.00
8,653.00
Provision for Tax
1,017.00
-1,586.00
1,707.00
1,625.00
4,886.00
1,764.00
Profit After Tax
2,179.00
-4,459.00
5,508.00
3,773.00
14,507.00
6,892.00
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
Adj to Profit After Tax
0.00
0.00
0.00
0.00
0.00
0.00
Profit Balance B/F
0.00
0.00
0.00
0.00
0.00
0.00
Profit Available for appropriations
0.00
0.00
0.00
0.00
0.00
0.00
Appropriations
0.00
0.00
0.00
0.00
0.00
0.00
Equity Dividend (%)
Earnings Per Share
17.85
-36.02
43.92
30.22
116.79
55.52
Profit And Loss Analysis Highlights
stock-summary

Net Sales

YoY Growth in year ended Mar 2026 is 21.91% vs -22.86% in Mar 2025

stock-summary

Operating Profit (PBDIT) excl Other Income

YoY Growth in year ended Mar 2026 is 106.72% vs -185.10% in Mar 2025

stock-summary

Interest

YoY Growth in year ended Mar 2026 is 156.77% vs 80.23% in Mar 2025

stock-summary

Profit After Tax

YoY Growth in year ended Mar 2026 is 148.87% vs -180.95% in Mar 2025

Compare Profit and Loss Results of JCR Pharmaceuticals Co., Ltd.
Markets Mojo
Figures in Million
consolidated - Profit And Loss Results
Markets Mojo
Markets Mojo
Change(JPY)
Change(%)
No of Months
12
12
Operating Income
40,319.00
2,01,676.00
-1,61,357.00
-80.01%
Less :Inter divisional transfers
0.00
0.00
0.00
0%
Less: Excise
0.00
0.00
0.00
0%
Net Sales
40,319.00
2,01,676.00
-1,61,357.00
-80.01%
Expenditure (Ex Depriciation)
Stock Adjustments
0.00
0.00
0.00
0%
Raw Materials Consumed
0.00
0.00
0.00
0%
Power & Fuel Cost
0.00
0.00
0.00
0%
Employee Cost
0.00
0.00
0.00
0%
Operating Expenses
398.00
1,757.00
-1,359.00
-77.35%
General and Administration Expenses
12,868.00
26,056.00
-13,188.00
-50.61%
Selling and Distribution Expenses
0.00
0.00
0.00
0%
Cost of Software developments
0.00
0.00
0.00
0%
Miscellaneous Expenses
0.00
0.00
0.00
0%
Expenses Capitalised
0.00
0.00
0.00
0%
Total Expenditure
39,888.00
1,81,326.00
-1,41,438.00
-78.00%
Operating Profit (PBDIT) excl Other Income
431.00
20,350.00
-19,919.00
-97.88%
Other Income
1,310.00
-341.00
1,651.00
484.16%
Operating Profit (PBDIT)
4,298.00
36,011.00
-31,713.00
-88.06%
Interest
398.00
1,757.00
-1,359.00
-77.35%
Profit before Depriciation and Tax
0.00
0.00
0.00
0%
Depreciation
2,557.00
16,002.00
-13,445.00
-84.02%
Profit Before Taxation & Exceptional Items
0.00
0.00
0.00
0%
Exceptional Income / Expenses
0.00
0.00
0.00
0%
Profit Before Tax
3,224.00
14,273.00
-11,049.00
-77.41%
Provision for Tax
1,017.00
2,737.00
-1,720.00
-62.84%
Profit After Tax
2,179.00
11,536.00
-9,357.00
-81.11%
Extraordinary Items
0.00
0.00
0.00
0%
Adj to Profit After Tax
0.00
0.00
0.00
0%
Profit Balance B/F
0.00
0.00
0.00
0%
Profit Available for appropriations
0.00
0.00
0.00
0%
Appropriations
0.00
0.00
0.00
0%
Equity Dividend (%)
0%
0%
0.00
Earnings Per Share
17.8509
90.1032
-72.25
-80.19%
Profit And Loss - Net Sales
Net Sales 40,319.00 Million
in Mar 2026

Figures in Million
stock-summary

YoY Growth in year ended Mar 2026 is 21.91% vs -22.86% in Mar 2025

Profit And Loss - Operating Profit (PBDIT)
Operating Profit (PBDIT) 431.00 Million
in Mar 2026

Figures in Million
stock-summary

YoY Growth in year ended Mar 2026 is 106.72% vs -185.10% in Mar 2025

Profit And Loss - Interest
Interest 398.00 Million
in Mar 2026

Figures in Million
stock-summary

YoY Growth in year ended Mar 2026 is 156.77% vs 80.23% in Mar 2025

Profit And Loss - Profit After Tax
Profit After Tax 2,179.00 Million
in Mar 2026

Figures in Million
stock-summary

YoY Growth in year ended Mar 2026 is 148.87% vs -180.95% in Mar 2025